Search Results

Your search returned 443 results. You are on page 5 of 45.

4 January 2016

Companies active in corporate social responsibility also try to avoid paying taxes, says study

Author: Economist (UK)

"Social saints, fiscal fiends", 2 Jan 2016...

Read more

16 November 2015
+ Français - Hide

Author: 20 Minutes

« Pneumonie: Médecins sans frontières exige une baisse du prix du vaccin », 13 novembre 2015...

Read more

22 September 2015
+ Español - Hide


 “Standard & Poor's lanza su Índice 500 de Valores Católicos”, 21 de Septiembre de 2015...

Read more

11 May 2015

The new U.S. office politics: funding your boss's political causes

Author: Michelle Conlin & Lucas Iberico Lozada, Reuters (UK)

...[E]mployers are increasingly approaching workers to fundraise, lobby and campaign in ways they never have before, according to a Reuters analysis of FEC filings and data compiled by the Business Industry Political Action Committee... [Since] a 2010...

Read more

9 April 2015

Improving maternal health and access to contraceptives: Pharmaceutical companies’ contribution to MDG 5

Author: Access to Medicine Foundation

Pharmaceutical companies operationalise commitments to MDG 5 with a variety of initiatives. Ten of the world’s largest pharmaceutical companies are taking some action to improve access to maternal health and family planning, by making public...

Read more

11 February 2015

Pfizer announces decision to lower price of pneumococcal vaccine but critics call reduction "meager"

See full story

3 February 2015

Pfizer to further reduce Prevenar 13 price in poorest nations

Author: Axonn News Agency

Pfizer has announced that it will be taking new steps to make its Prevenar 13 vaccine accessible to people in poor countries through a new agreement with the Gavi Alliance. The company has committed to a 20 cent reduction of its per-dose price for the...

Read more

27 January 2015

Pfizer Discount for its Pneumococcal Vaccine is Criticized as ‘Meager’

Author: Ed Silverman, Wall Street Journal

File this under ‘just not good enough.’ One week after being slammed over the price that poor countries pay for its pneumococcal vaccine, Pfizer PFE +3.27% announced a 6% reduction. This would bring the cost of its Prevenar 13 vaccine down 20 cents, to...

Read more

19 January 2015

GlaxoSmithKline & Pfizer must lower prices to make vaccines needed by children affordable in poorer countries, says MSF

Author: Sarah Boseley, Guardian (UK)

In a new report on vaccine pricing, MSF says British company GlaxoSmithKline(GSK) and US giant Pfizer should slash the price of the vaccines to $5 (£3.20) per child in developing countries....“We have an irrational situation where some developing coun...

Read more

22 December 2014

Corporate Legal Accountability Quarterly Bulletin - Issue 15, December 2014

Author: Business and Human Rights Resource Centre

Welcome to our redesigned Corporate Legal Accountability Quarterly Bulletin, streamlined to highlight a noteworthy issue each quarter, as well as key developments.  The Corporate Legal Accountability hub on our website provides objective, concise...

Read more